pca cell lines (ATCC)
99
Structured Review
ATCC
pca cell lines
Pca Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8692 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pca/DU+145/pmc13101708-35-0-9
Average 99 stars, based on 8692 article reviews
Pca Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8692 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pca/DU+145/pmc13101708-35-0-9
Average 99 stars, based on 8692 article reviews
pca cell lines - by Bioz Stars,
2026-11
99/100 stars
Images
Related Articles
Cell Culture:Article Title: ENO1 Is More Abundant than ENO2 on the Surface of Metastatic and Neuroendocrine Prostate Cancer Cells and Upregulated in High-Risk Prostate Tumors Article Snippet: .. The PCa cell lines PC3, Article Title: Electrospun Poly(lactide-co-glycolide-co-ε-caprolactone) as a Bioresorbable Platform for Docetaxel-Degradation, Drug Delivery Study and Anticancer Activity Article Snippet: Non-cancerous cells (the L-929 mouse subcutaneous fibroblast cell line, ATCC CCL-1 TM ) were cultured in ATCC-formulated Eagle’s Minimum Essential Medium (MEM). .. Human prostate cancer PC-3 cells (ATCC CRL-1435 TM ) were cultured in F-12K medium (Merck, Poznan, Poland) and the Article Title: FOXA1-driven ELOVL7 promotes lipid metabolic reprogramming and malignant progression in prostate cancer Article Snippet: Journal Pre-proof FOXA1-driven ELOVL7 promotes lipid metabolic reprogramming and malignant progression in prostate cancer Changheng Yang PII: S0040-8166(26)00813-X DOI: https://doi.org/10.1016/j.tice.2026.104117 Reference: YTICE104117 To appear in: Tissue and Cell Received date: 23 June 2026 Revised date: 15 October 2026 Accepted date: 1 November 2026 Please cite this article as: Changheng Yang, FOXA1-driven ELOVL7 promotes lipid metabolic reprogramming and malignant progression in prostate cancer, Tissue and Cell, (2026) doi:https://doi.org/10.1016/j.tice.2026.104117 This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Transfection:Article Title: FOXA1-driven ELOVL7 promotes lipid metabolic reprogramming and malignant progression in prostate cancer Article Snippet: Journal Pre-proof FOXA1-driven ELOVL7 promotes lipid metabolic reprogramming and malignant progression in prostate cancer Changheng Yang PII: S0040-8166(26)00813-X DOI: https://doi.org/10.1016/j.tice.2026.104117 Reference: YTICE104117 To appear in: Tissue and Cell Received date: 23 June 2026 Revised date: 15 October 2026 Accepted date: 1 November 2026 Please cite this article as: Changheng Yang, FOXA1-driven ELOVL7 promotes lipid metabolic reprogramming and malignant progression in prostate cancer, Tissue and Cell, (2026) doi:https://doi.org/10.1016/j.tice.2026.104117 This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Multiple Displacement Amplification:Article Title: Circulating FABP4 promotes obesity-associated breast cancer lung metastasis through PIP2. Article Snippet: Inc Cat# D12450J Dexamethasone MilliporeSigma Cat# D4902 Rosiglitazone MilliporeSigma Cat# R2408 IBMX MilliporeSigma Cat# I7018 Insulin MilliporeSigma Cat# I9278 FABP4 (human recombinant) FITC conjugated Cayman Cat# 9001068 MammoCultTM Human Medium Kit STEMCELL technologies Cat# 5620 Collagen I, rat tail ThermoFisher science Cat# A1048301 MitoSOXTM Mitochondrial Superoxide Indicators, for live-cell imaging (MitoSox Red) Invitrogen Cat# M36008 DCFDA/H2DCFDA - Cellular ROS Assay Kit Abcam Cat# ab113851 (Continued on next page) 18 Cell Reports ▪▪, 117788, ▪▪, 2026 Article ll OPEN ACCESS .. The cancer cell lines MDA-MB-231, E0771, 4T1, AU565, MCF7, PC3, Article Title: CDH3-directed immunotherapy targets basal-like hormone receptor negative prostate cancer and breast cancer. Article Snippet: .. |